Laporan Laba Rugi (TTM)
Laporan Laba Rugi Nextage Therapeutics Ltd - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 12-31 |
2021 12-31 |
2023 12-31 |
2024 12-31 |
|
---|---|---|---|---|
Revenue | 0 | 0 | 1 | 0 |
Change (%) | -52.36 | 862.64 | -52.85 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 0 | 0 | 1 | 0 |
Change (%) | 29.31 | 768.00 | -48.23 | |
% of Revenue | 30.37 | 82.42 | 74.32 | 81.60 |
Gross Operating Profit | 0 | 0 | 0 | 0 |
Change (%) | -87.97 | 1,306.25 | -66.22 | |
% of Revenue | 69.63 | 17.58 | 25.68 | 18.40 |
SG&A | 6 | 5 | 3 | 3 |
Change (%) | -9.53 | -36.25 | 4.60 | |
% of Revenue | 2,937.70 | 5,578.02 | 369.41 | 819.61 |
R&D | 1 | 0 | ||
Change (%) | -86.68 | |||
% of Revenue | 111.42 | 31.48 | ||
OpEx | 7 | 7 | 5 | 4 |
Change (%) | 9.49 | -32.57 | -20.79 | |
% of Revenue | 3,448.69 | 7,925.27 | 555.14 | 932.69 |
Operating Income | -6 | -7 | -4 | -3 |
Change (%) | 11.34 | -44.01 | -13.74 | |
% of Revenue | -3,348.69 | -7,825.27 | -455.14 | -832.69 |
Interest Expense | -0 | -0 | -0 | -0 |
Change (%) | 50.00 | -68.55 | -46.00 | |
% of Revenue | -55.50 | -174.73 | -5.71 | -6.54 |
Net Income | -16 | -8 | -4 | -3 |
Change (%) | -51.60 | -49.81 | -15.36 | |
% of Revenue | -8,359.16 | -8,492.31 | -442.81 | -794.92 |
Source: Capital IQ